Can A REMS Mitigate CV Risks? Avandia, Meridia Offer Point, Counterpoint

 
• By Sue Sutter
  
3D illustration of a matrix with tablets and the words risks and benefits. Concept of clinical trials results - Illustration
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers